You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 267 No. 15, April 15, 1992 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Special Communication
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Related letter
 •Similar articles in JAMA
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Proxy Decision Making for Incompetent Patients

An Ethical and Empirical Analysis

Ezekiel J. Emanuel, MD, PhD; Linda L. Emanuel, MD, PhD

JAMA. 1992;267(15):2067-2071.

Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

RECENTLY, proxy or surrogate decision making regarding the termination of life-sustaining interventions for incompetent patients has been widely endorsed and promoted. After the Cruzan decision and the Patient Self-Determination Act of 1990, many states enacted proxy statutes specifically for health care. Indeed, even states such as New York and Massachusetts, which in the past had avoided enacting any legislation on living wills and securing the rights of patients, have quickly adopted

See also pp 2082 and 2101. health care proxy laws. Simultaneously with this growing enthusiasm for proxy decision making have arisen ethical and empirical doubts about whether proxies can select interventions that the patient would have selected. These divergent trends confront us just as there is a growing need to develop policies on this issue. Consequently, it is important to examine several questions on proxy decision making: How widely endorsed is proxy decision making? What is the justification of . . . [Full Text PDF of this Article]


Author Affiliations

From the Division of Cancer Epidemiology and Control, Dana-Farber Cancer Institute (Dr E. J. Emanuel) and the Division of Medical Ethics, Harvard Medical School (Dr L. L. Emanuel), Boston, Mass. Dr L. L. Emanuel is also a teaching and research scholar of the American College of Physicians.


Footnotes

Reprint requests to Dana-Farber Cancer Institute, 44 Binney St, Boston, MA 02115 (Dr E. J. Emanuel).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

RELATED LETTER

Ethics of Surrogate Consent for Living Organ Donation—Reply
David Wendler and Ezekiel Emanuel
JAMA. 2004;292(14):1685.
EXTRACT | FULL TEXT  






HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1992 American Medical Association. All Rights Reserved.